Altered amyloid plasma profile in patients with disabling headaches after SARS-CoV-2 infection and vaccination
View ORCID ProfileAnne Hege Aamodt, View ORCID ProfileThor Ueland, View ORCID ProfileMarion I. Boldingh, View ORCID ProfileBurcu Bezgal, Maria Argren, Cecilia Adele Dunne, View ORCID ProfileKari Otterdal, View ORCID ProfileIda Gregersen, Vigdis Bjerkeli, View ORCID ProfileAnnika Elisabet Michelsen, View ORCID ProfileAndreas Husøy, View ORCID ProfileÅse Hagen Morsund, View ORCID ProfileKristina Devik, View ORCID ProfileAnne Christine Poole, Kristine Gjendemsjø, Katrin Schlüter, View ORCID ProfileSara Maria Mathisen, Mari Aalstad-Johansen, View ORCID ProfileThor Skattør, Julie Sønnervik, View ORCID ProfileBirgitte Boye, View ORCID ProfileTrine Haug Popperud, View ORCID ProfileEinar August Høgestøl, Hanne Flinstad Harbo, View ORCID ProfileFridtjof Lund-Johansen, View ORCID ProfilePål Aukrust, View ORCID ProfileErling Tronvik, View ORCID ProfileTuva Børresdatter Dahl, Bente E. Halvorsen
doi: https://doi.org/10.1101/2024.10.19.24315794
Anne Hege Aamodt
1Department of Neurology, Oslo University Hospital, Oslo, Norway
2Department of Neuromedicine and Movement Science, the Norwegian University of Science and Technology, Trondheim, Norway
Thor Ueland
3Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway
4Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
5Thrombosis Research Center (TREC), Division of internal medicine, University Hospital of North Norway, Tromsø, Norway
Marion I. Boldingh
1Department of Neurology, Oslo University Hospital, Oslo, Norway
Burcu Bezgal
1Department of Neurology, Oslo University Hospital, Oslo, Norway
Maria Argren
1Department of Neurology, Oslo University Hospital, Oslo, Norway
4Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
Cecilia Adele Dunne
4Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
Kari Otterdal
3Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway
Ida Gregersen
3Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway
Vigdis Bjerkeli
3Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway
4Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
Annika Elisabet Michelsen
3Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway
4Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
Andreas Husøy
2Department of Neuromedicine and Movement Science, the Norwegian University of Science and Technology, Trondheim, Norway
6Department of Neurology of Clinical Neurophysiology, St. Olav Hospital, Trondheim, Norway
Åse Hagen Morsund
7Department of Neurology, Molde Hospital, Molde, Norway
Kristina Devik
1Department of Neurology, Oslo University Hospital, Oslo, Norway
8Department of Neurology, Namsos Hospital, Molde, Norway
Anne Christine Poole
9Oslo Headache Centre, Oslo, Norway
Kristine Gjendemsjø
10Sandvika Neuro Centre, Sandvika, Norway
Katrin Schlüter
11Department of Neurology, Stavanger University Hospital, Stavanger, Norway
Sara Maria Mathisen
11Department of Neurology, Stavanger University Hospital, Stavanger, Norway
Mari Aalstad-Johansen
12Department of Neurology, Innlandet Hospital Trust, Lillehammer, Norway
Thor Skattør
1Department of Neurology, Oslo University Hospital, Oslo, Norway
4Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
13Department of Radiology, Oslo University Hospital, Oslo, Norway
Julie Sønnervik
14Hodeverket, Sandnes, Norway
Birgitte Boye
15Unit Psychosomatic medicine and CL psychiatry, Oslo University Hospital, Oslo, Norway
16Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway
Trine Haug Popperud
1Department of Neurology, Oslo University Hospital, Oslo, Norway
Einar August Høgestøl
1Department of Neurology, Oslo University Hospital, Oslo, Norway
4Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
Hanne Flinstad Harbo
1Department of Neurology, Oslo University Hospital, Oslo, Norway
4Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
Fridtjof Lund-Johansen
4Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
17Department of Immunology, Oslo University Hospital, Oslo, Norway
Pål Aukrust
3Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway
4Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
18Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Oslo, Norway
Erling Tronvik
2Department of Neuromedicine and Movement Science, the Norwegian University of Science and Technology, Trondheim, Norway
6Department of Neurology of Clinical Neurophysiology, St. Olav Hospital, Trondheim, Norway
Tuva Børresdatter Dahl
3Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway
Bente E. Halvorsen
3Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway
4Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
19Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted October 22, 2024.
Altered amyloid plasma profile in patients with disabling headaches after SARS-CoV-2 infection and vaccination
Anne Hege Aamodt, Thor Ueland, Marion I. Boldingh, Burcu Bezgal, Maria Argren, Cecilia Adele Dunne, Kari Otterdal, Ida Gregersen, Vigdis Bjerkeli, Annika Elisabet Michelsen, Andreas Husøy, Åse Hagen Morsund, Kristina Devik, Anne Christine Poole, Kristine Gjendemsjø, Katrin Schlüter, Sara Maria Mathisen, Mari Aalstad-Johansen, Thor Skattør, Julie Sønnervik, Birgitte Boye, Trine Haug Popperud, Einar August Høgestøl, Hanne Flinstad Harbo, Fridtjof Lund-Johansen, Pål Aukrust, Erling Tronvik, Tuva Børresdatter Dahl, Bente E. Halvorsen
medRxiv 2024.10.19.24315794; doi: https://doi.org/10.1101/2024.10.19.24315794
Altered amyloid plasma profile in patients with disabling headaches after SARS-CoV-2 infection and vaccination
Anne Hege Aamodt, Thor Ueland, Marion I. Boldingh, Burcu Bezgal, Maria Argren, Cecilia Adele Dunne, Kari Otterdal, Ida Gregersen, Vigdis Bjerkeli, Annika Elisabet Michelsen, Andreas Husøy, Åse Hagen Morsund, Kristina Devik, Anne Christine Poole, Kristine Gjendemsjø, Katrin Schlüter, Sara Maria Mathisen, Mari Aalstad-Johansen, Thor Skattør, Julie Sønnervik, Birgitte Boye, Trine Haug Popperud, Einar August Høgestøl, Hanne Flinstad Harbo, Fridtjof Lund-Johansen, Pål Aukrust, Erling Tronvik, Tuva Børresdatter Dahl, Bente E. Halvorsen
medRxiv 2024.10.19.24315794; doi: https://doi.org/10.1101/2024.10.19.24315794
Subject Area
Subject Areas
- Addiction Medicine (400)
- Allergy and Immunology (711)
- Anesthesia (202)
- Cardiovascular Medicine (2954)
- Dermatology (250)
- Emergency Medicine (443)
- Epidemiology (12766)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4600)
- Geriatric Medicine (420)
- Health Economics (731)
- Health Informatics (2934)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (926)
- Medical Education (427)
- Medical Ethics (116)
- Nephrology (471)
- Neurology (4377)
- Nursing (237)
- Nutrition (640)
- Oncology (2279)
- Ophthalmology (648)
- Orthopedics (258)
- Otolaryngology (326)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1197)
- Primary Care Research (499)
- Public and Global Health (6963)
- Radiology and Imaging (1534)
- Respiratory Medicine (916)
- Rheumatology (442)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (181)